Comment on Revised ISHAM-ABPA Guidelines for Diagnosing and Treating ABPA/Mycoses

02 Apr 20264 min read0 viewsJournal Feed

GIST (Key Takeaways)

Extract We read with great interest the diagnostic criteria for allergic bronchopulmonary aspergillosis/mycoses (ABPA/M) proposed by the International Society for Human and Animal Mycology (ISHAM) working group [1], that was recently published in the European Respiratory Journal .
A garwal et al .
[2] reported that Aspergillus fumigatus sensitisation affects up to 25% of adult asthmatic patients presenting to tertiary care centres, with nearly 37% of sensitised individuals progressing to ABPA.

Clinical Editorial

European Respiratory Journal published a clinical update in Critical Care on 02 Apr 2026.

The item focuses on Comment on: Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Review the original article for the full source wording and details.